Detection of Rep+ cells was more frequently associated with M2-like (CD68+CD163+) MPs, as demonstrated by an increased number of Rep+CD68+CD163+ triple positive cells in comparison to Rep+ non-M2-like MPs (Rep+CD68+CD163− cells) in both tumor-distant (mean 6.1% vs. 0.7%, p < 0.0001) and peritumor tissues (5.3% vs. 0.5%, p < 0.001; Figure 4E). The gene discussed is CD163; the disease is neoplasm.